Drug
Pelabresib
Pelabresib: highest development phase Phase 3, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pelabresib NCT07357727 | Phase 3 | Primary Myelofibrosis (PMF) |
Latest
No recent events.
Follow Pelabresib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.